#1
|
||||
|
||||
Ìàòåðèàëû ïî ñîñóäèñòîé õèðóðãèè
Òðàíñàòëàíòè÷åñêèé ñîãëàñèòåëüíûé äîêóìåíò ïî âåäåíèþ áîëüíûõ ñ çàáîëåâàíèÿìè ïåðèôåðè÷åñêèõ àðòåðèé TASC II, 2007.
[Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ] Çäåñü ìîæíî ñêà÷àòü ñîáñòâåííî [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ] (ôîðìàò pdf, àíãë.) [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ] Ðåêîìåíäàöèè Ðîññèéñêîãî îáùåñòâà àíãèîëîãîâ è ñîñóäèñòûõ õèðóðãîâ, 2007. (ôîðìàò pdf, ðóñ.)
__________________
Èëþõèí Åâãåíèé Àðêàäüåâè÷ |
#2
|
|||
|
|||
Íåìåöêèå ãàéäëàéíû 2009 ãîäà ïî äèàãíîñòèêå è ëå÷åíèþ çàáîëåâàíèé ïåðèôåðè÷åñêèõ àðòåðèé:
S3-Leitlinie zur Diagnostik und Therapie der peripheren arteriellen Verschlusskrankheit (PAVK), Stand 2009 [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ] |
#3
|
|||
|
|||
TASC II ïî ðóññêè
[Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]
|
#4
|
|||
|
|||
[Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]
Âåðîÿòíî, ýòè îòå÷åñòâåííûå ðåêîìåíäàöèè 2010 ãîäà óæå îïóáëèêîâàíû. |
#5
|
|||
|
|||
ACC/AHA 2005 Guidelines for the Management of Patients With Peripheral Arterial Disease (Lower Extremity, Renal, Mesenteric, and Abdominal Aortic)
[Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ] |
#6
|
|||
|
|||
Òîæå ïî òåìå:
2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic Disease [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ] Ìîæåò åùå ñ ôîðóìà ðåíòãåíõèðóðãîâ â ýòó òåìó ïåðåíåñòè ññûëêó íà ïîñëåäíèå ðåêîìåíäàöèè ïî áðàõèîöåôàëüíûì àðòåðèÿì? |
#7
|
|||
|
|||
Ðåêîìåíäàöèè ïî ìåðîïðèÿòèÿì äëÿ ïàöèåíòîâ ñ çàáîëåâàíèÿìè ïåðèôåðè÷åñêèõ àðòåðèé: ACCF/AHA/ACR/SCAI/SIR/SVM/SVN/SVS 2010 Performance Measures for Adults With Peripheral Artery Disease
[Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ] |
#8
|
||||
|
||||
NICE technology appraisal guidance
[Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ] PDF âåðñèÿ [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]. Ïåðåìåùåíî â ñîñóäèñòóþ õèðóðãèþ. Ìîäåðàòîð.
__________________
Òîëüêî ïîìíèòå: ôîðóì - íå çàìåíà î÷íîìó âðà÷ó, à ëå÷åíèå ïî èíòåðíåòó - ÷ðåâàòî ñìåðòüþ îò îïå÷àòêè. Ñ óâàæåíèåì, Ñåðãåé Àëåêñàíäðîâè÷. |
#9
|
||||
|
||||
2011 ASA/ACCF/AHA/AANN/AANS/ACR/ASNR/CNS/SAIP/SCAI/SIR/SNIS/SVM/SVS Guideline on the Management of Patients With Extracranial Carotid and Vertebral Artery Disease
[Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ] Ñåé÷àñ íà÷íåòñÿ îòïóñê è çàêîí÷ó ïåðåâîä (6 ñòðàíèö îñòàëîñü). Åñëè êòî-òî ðàíüøå óïðàâèòñÿ, íå îáèæóñü. |
#10
|
||||
|
||||
Intersocietal Commission for the Accreditation of Vascular Laboratories (ICAVL)
[Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ] ICAVL STANDARDS FOR ACCREDITATION IN NONINVASIVE VASCULAR TESTING [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ] Ïîñëåäíèå èçìåíåíèÿ â ñòàíäàðòàõ [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ] |
#11
|
|||
|
|||
2011 ACCF/AHA Focused Update of the Guideline for the Management of Patients With Peripheral Artery Disease (Updating the 2005 Guideline)
[Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ] |